People · Operator
Named in public records as an officer, director or promoter · active 2009–2024 · Biotechnology, Other, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| AltheaDx, Inc. | — | Biotechnology | Series B | $51.8M | $137.3M | 2009 |
| Magstim Group Inc | — | Other | Series B | $32.1M | $532.6M | 2015 |
| Emerging Therapy Solutions, Inc. | — | Other Health Care | Series A | $24.3M | $26.8M | 2020 |
| Althea Technologies Inc | — | Other | Pre-Seed | $553K | $12.8M | 2010 |
J. Matthew Mackowski at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside J. Matthew Mackowski on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| James B Glavin | 2 | 2 |
| Deval A Lashkari | 2 | 2 |
| Wei Li | 1 | 7 |
| Kevin Roche | 1 | 6 |
| Magda Marquet | 1 | 6 |
| David McLean | 1 | 5 |
| David Nikodem | 1 | 4 |
| Jason Liu | 1 | 4 |
| Andrew Jackson | 1 | 4 |
| John Wu | 1 | 4 |
| Jeffrey G. Black | 1 | 3 |
| Jeanette Welsh | 1 | 3 |
| Thomas A. Raffin | 1 | 2 |
| Magda T. Marquet | 1 | 2 |
| Yuh-geng Tsay | 1 | 2 |
| Nathan Schmidt | 1 | 2 |
| Francois Ferre | 1 | 2 |
| James G. Glavin | 1 | 1 |
| Ann Matthew Kessler | 1 | 1 |
| Carin Sandvik | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.